MSB Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE - 19th Jul 2022, 9:54am

annb0t

annb0t

Top 20
MSB Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
Price Sensitive: Y
Date: 19th Jul 2022, 9:54am

>>> Read announcement: Google: MSB Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
MSB Ann: FDA Grants RMAT Designation for Rexlemestrocel-L in CLBP - 9th Feb 2023, 9:39am
Replies
0
Views
144
annb0t
annb0t
annb0t
MSB Ann: Rexlemestrocel-L to be Highlighted on Heart Failure Panel - 12th Jul 2022, 9:56am
Replies
0
Views
232
annb0t
annb0t
annb0t
MSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 31st Oct 2023, 10:06am
Replies
0
Views
96
annb0t
annb0t
annb0t
MSB Ann: Annual Report to Shareholders - 30th Oct 2023, 9:02am
Replies
0
Views
82
annb0t
annb0t
annb0t
MSB Ann: Notice of Annual General Meeting and Proxy Form - 30th Oct 2023, 8:58am
Replies
0
Views
92
annb0t
annb0t
Top Bottom